Who owns Corvus Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRVS from SEC Form 13F filings across 173 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 173 institutions disclosed 70.7M shares of Corvus Pharmaceuticals, Inc. worth $1.06B — about 76.5% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
173
13F holders
$1.06B
value, 2026 filers
76.5%
of shares outstanding (70.7M sh)
40
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CRVS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 7.2M | $107.0M | 2.0% | 7.8% | 0.0% |
| 2 | BlackRock, Inc. | 7.1M | $106.7M | 0.0% | 7.7% | +15.9% |
| 3 | STATE STREET CORP | 4.5M | $66.8M | 0.0% | 4.8% | +25.5% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.8M | $56.6M | 0.0% | 4.1% | +29.9% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $49.2M | 0.0% | 3.6% | +1.8% |
| 6 | ADAMS STREET PARTNERS LLC | 3.3M | $48.9M | 11.1% | 3.5% | 0.0% |
| 7 | Vivo Capital, LLC | 2.8M | $41.9M | 3.8% | 3% | 0.0% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 2.7M | $40.8M | 0.0% | 3% | +17.8% |
| 9 | PERCEPTIVE ADVISORS LLC | 2.7M | $39.9M | 0.6% | 2.9% | +16.4% |
| 10 | Deep Track Capital, LP | 2.5M | $37.2M | 0.5% | 2.7% | 0.0% |
| 11 | BRAIDWELL LP | 2.1M | $31.8M | 1.2% | 2.3% | +21.3% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $27.7M | 0.0% | 2% | +8.2% |
| 13 | Foresite Capital Management VI LLC | 1.8M | $27.4M | 4.3% | 2% | 0.0% |
| 14 | GOLDMAN SACHS GROUP INC | 1.6M | $23.6M | 0.0% | 1.7% | +2.3% |
| 15 | Hood River Capital Management LLC | 1.6M | $23.5M | 0.2% | 1.7% | +17.7% |
| 16 | MORGAN STANLEY | 1.3M | $20.1M | 0.0% | 1.5% | -46.2% |
| 17 | Boxer Capital Management, LLC | 1.1M | $16.4M | 1.2% | 1.2% | 0.0% |
| 18 | Catalio Capital Management, LP | 1.1M | $16.1M | 3.0% | 1.2% | +21.2% |
| 19 | MILLENNIUM MANAGEMENT LLC | 1.0M | $15.7M | 0.0% | 1.1% | +21.0% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 814,750 | $12.2M | 0.0% | 0.9% | +21.6% |
| 21 | TWO SIGMA INVESTMENTS, LP | 785,208 | $11.7M | 0.0% | 0.9% | +45.4% |
| 22 | BANK OF AMERICA CORP /DE/ | 757,798 | $11.3M | 0.0% | 0.8% | +219.7% |
| 23 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $11.2M | 0.0% | 0.8% | 0.0% |
| 24 | Eversept Partners, LPNEW | 747,994 | $11.2M | 0.6% | 0.8% | new |
| 25 | EMERALD ADVISERS, LLC | 685,683 | $10.2M | 0.2% | 0.7% | -0.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.